Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LKL International BhdXKLS:0182 +16.67% Debt-to-Equity is 0.44 as of Mar. 2026, which is 193% above its 10-year median of 0.15. The stock has 5 warning signs investors should review. Among 703 Medical Devices & Instruments companies, LKL International Bhd ranks worse than 66.71% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for LKL International Bhd's Debt-to-Equity or its related term are showing as below:
XKLS:0182'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.15 Max: 0.47
Current: 0.44
During the past 10 years, the highest Debt-to-Equity Ratio of LKL International Bhd was 0.47. The lowest was 0.03. And the median was 0.15.
XKLS:0182's Debt-to-Equity is ranked worse than 66.71% of 703
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs XKLS:0182: 0.44
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
LKL International Bhd Debt-to-Equity Related Terms
LKL International Bhd Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for LKL International Bhd's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0182 vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, LKL International Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LKL International Bhd Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where LKL International Bhd's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LKL International Bhd (XKLS:0182) has a Debt-to-Equity of 0.44 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LKL International Bhd and its competitors. This is 193% above median its historical median of 0.15. Over the past decade, LKL International Bhd's Debt-to-Equity has ranged from 0.03 to 0.47. According to the industry distribution chart, LKL International Bhd ranks #469 out of 703 companies in the Medical Devices & Instruments industry, placing it in the top 66.7%.
Is LKL International Bhd's Debt-to-Equity too high?
LKL International Bhd's current Debt-to-Equity of 0.44 is 193% above median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.47. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. LKL International Bhd's value of 0.44 is 91.3% above this industry median. Based on the distribution chart, LKL International Bhd ranks #469 out of 703 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does LKL International Bhd's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, LKL International Bhd ranks #469 out of 703 companies for Debt-to-Equity. This places LKL International Bhd in the lower half of its industry. The industry median Debt-to-Equity is 0.23. LKL International Bhd's value of 0.44 is 91.3% above this benchmark. Historically, LKL International Bhd's own Debt-to-Equity has ranged from 0.03 to 0.47 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 0.23, LKL International Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LKL International Bhd's current Debt-to-Equity of 0.44 is 91.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LKL International Bhd and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LKL International Bhd's current Debt-to-Equity is 0.44, which is 193% above median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.04 — trading 30% below its estimated fair value. The current Debt-to-Equity is 0.44, which is 193% above median its 10-year median of 0.15 and 91.3% above the Medical Devices & Instruments industry median of 0.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current Debt-to-Equity is 0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0182 has been successfully added to your 
